Inhaled corticosteroids versus long-acting beta -agonists for chronic obstructive pulmonary disease (Review).

More search options...

Spencer, S; Karner, C; Cates, CJ; Evans, DJ (2011) Inhaled corticosteroids versus long-acting beta -agonists for chronic obstructive pulmonary disease (Review). Cochrane Database Syst Rev (12). i- 55. https://doi.org/10.1002/14651858.CD007033.pub3
SGUL Authors: Cates, Christopher Joseph

Preview

["document_typename_application/pdf; charset=binary" not defined] Published Version
Available under License St George's repository terms & conditions.
Download (721kB) | Preview

Abstract

Long-acting beta(2)-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler. However, the relative added value of the two individual components is unclear.

Item Type:

Article

Additional Information:

This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2011, Issue 12. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review. Cates CJ, Evans DJ. Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease.Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD007033. DOI: 10.1002/14651858.CD007033.pub3.

Keywords:

Adrenal Cortex Hormones, Adrenergic beta-2 Receptor Agonists, Albuterol, Androstadienes, Bronchodilator Agents, Budesonide, Ethanolamines, Humans, Pulmonary Disease, Chronic Obstructive, Randomized Controlled Trials as Topic

SGUL Research Institute / Research Centre:

Academic Structure > Population Health Research Institute (INPH)

Journal or Publication Title:

Cochrane Database Syst Rev

Dates: